The Cell And Gene Therapy Clinical Trials Market was valued at USD 9.48 billion in 2023 and is projected to witness exponential growth, reaching USD 32.96 billion by 2032, at a CAGR of 14.87% over the forecast period 2024-2032. This surge is attributed to increasing research and development (R&D) in regenerative medicine, rising prevalence of genetic...